Biotech · Private company
MedPacto, Inc.
Track this companyFree. Adds MedPacto, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials51 recruiting or active
Pipeline programs4From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline4
- VactosertibPhase 2 · OsteosarcomaClinicalTrials.gov · fetched Nov 12, 2026
- Vactosertib(TEW-7197)/ DurvalumabPhase 2 · Urothelial Carcinoma RecurrentClinicalTrials.gov · fetched Nov 12, 2026
- TEW-7197Phase 1 · Advanced Stage Solid TumorsClinicalTrials.gov · fetched Nov 12, 2026
- TEW-7197Phase 1 · Myelodysplastic SyndromesClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials5
- Study to Assess Safety and Efficacy of Vactosertib in Adolescents and Adults With Recurrent, Refractory or Progressive OsteosarcomaPHASE1_PHASE2 · RECRUITING · started May 1, 2023ClinicalTrials.gov NCT05588648 · fetched Nov 12, 2026
- Vactosertib with Durvalumab in Urothelial Carcinoma Failing Checkpoint InhibitionPHASE2 · WITHDRAWN · started Dec 13, 2019ClinicalTrials.gov NCT04064190 · fetched Nov 12, 2026
- Preoperative Immunotherapy (Pembrolizumab) for Patients With Colorectal Cancer and Resectable Hepatic MetastasesPHASE2 · TERMINATED · started Jul 22, 2019ClinicalTrials.gov NCT03844750 · fetched Nov 12, 2026
- Dose Escalation and Proof-of-Concept Studies of Vactosertib (TEW-7197) Monotherapy in Patients With MDSPHASE1 · COMPLETED · started Jan 4, 2018ClinicalTrials.gov NCT03074006 · fetched Nov 12, 2026
- First in Human Dose Escalation Study of Vactosertib (TEW-7197) in Subjects With Advanced Stage Solid TumorsPHASE1 · COMPLETED · started Jul 29, 2014ClinicalTrials.gov NCT02160106 · fetched Nov 12, 2026